CIK 0002028614 · <br>Emerging growth company
Drugs Made In America Acquisition Corp.
Sign in to watch- Ticker
- DMAA
- Exchange
- Nasdaq
- Industry
- Blank Checks
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 646-726-7074
- Business address
- 420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170
Securities
- DMAA Ordinary Shares Nasdaq
- DMAAR Rights Nasdaq
- DMAAU Units Nasdaq
- DEFR14A Other DEFR14A
- NT 10-K Other NT 10-K
- NT 10-Q Other NT 10-Q
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- CERT Other Certification
- EFFECT Other Notice of Effectiveness
- 8-A12B Other Registration of Securities
Page 1 of 1 · 10 filings